Issue: February 2021
February 18, 2021
1 min read
Save

SOLOIST-WHF

Issue: February 2021
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Trial Scorecard: SOLOIST-WHF

Sotagliflozin (Zynquista, Lexicon/Sanofi) vs. placebo in patients with type 2 diabetes recently hospitalized for worsening HF.